Symbols / ENGN Stock $1.67 +1.21% enGene Therapeutics Inc.

Healthcare • Biotechnology • Canada • NCM
ENGN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Ronald H. W. Cooper
Exch · Country NCM · Canada
Market Cap 111.87M
Enterprise Value -130.61M
Income -122.44M
Sales —
FCF (ttm) -65.30M
Book/sh 4.20
Cash/sh 4.12
Employees 81
Insider 10d —
IPO Feb 01, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.84
PEG —
P/S —
P/B 0.40
P/C —
EV/EBITDA 1.03
EV/Sales —
Quick Ratio 11.36
Current Ratio 11.75
Debt/Eq 11.89
LT Debt/Eq —
EPS (ttm) -2.25
EPS next Y -1.99
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-09
Earnings (prior) 2026-03-09
ROA -25.63%
ROE -46.07%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 66.99M
Shs Float 22.49M
Insider Own 0.09%
Instit Own 102.44%
Short Float 2.98%
Short Ratio 0.45
Short Interest 1.62M
52W High 12.25
vs 52W High -86.37%
52W Low 1.40
vs 52W Low 19.29%
Beta -0.29
Impl. Vol. 25.00%
Rel Volume 0.31
Avg Volume 1.58M
Volume 492.05K
Target (mean) $3.57
Tgt Median $4.00
Tgt Low $2.00
Tgt High $6.00
# Analysts 7
Recom None
Prev Close $1.65
Price $1.67
Change 1.21%
About

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.57
Mean price target
2. Current target
$1.67
Latest analyst target
3. DCF / Fair value
$-17.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.67
Low
$2.00
High
$6.00
Mean
$3.57

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-14 main UBS Neutral → Neutral $2
2026-05-08 down Citizens Market Outperform → Market Perform —
2026-05-08 down Guggenheim Buy → Neutral —
2026-05-08 down Wells Fargo Overweight → Equal-Weight $2
2026-05-08 main HC Wainwright & Co. Buy → Buy $6
2026-05-08 down Piper Sandler Overweight → Neutral $4
2026-04-13 init WBB Securities — → Buy $22
2026-03-11 main Oppenheimer Outperform → Outperform $30
2026-03-09 reit HC Wainwright & Co. Buy → Buy $25
2025-11-12 main Morgan Stanley Overweight → Overweight $19
2025-11-12 reit Oppenheimer Outperform → Outperform $33
2025-11-12 main UBS Neutral → Neutral $10
2025-11-12 main Citizens Market Outperform → Market Outperform $21
2025-09-12 main Morgan Stanley Overweight → Overweight $18
2025-09-12 reit HC Wainwright & Co. Buy → Buy $25
2025-09-08 reit HC Wainwright & Co. Buy → Buy $25
2025-04-29 reit JMP Securities Market Outperform → Market Outperform $18
2025-03-11 main Morgan Stanley Overweight → Overweight $34
2025-03-11 reit HC Wainwright & Co. Buy → Buy $25
2025-02-18 init Piper Sandler — → Overweight $26
News
RSS: Latest ENGN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-10-30 FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UA Beneficial Owner of more than 10% of a Class of Security — 561,797 $8.90 $4,999,993
2024-10-08 FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UA Beneficial Owner of more than 10% of a Class of Security — 470,633 $5.94 $3,012,674
2024-09-27 COOPER RONALD HAROLD WILFRED Chief Executive Officer — 10,000 $5.70 $57,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
123.17
+97.71%
62.30
+139.05%
26.06
+34.14%
19.43
Research And Development
94.48
+146.59%
38.31
+132.80%
16.46
+6.41%
15.47
Selling General And Administration
28.68
+19.61%
23.98
+183.14%
8.47
+159.82%
3.26
General And Administrative Expense
28.68
+19.61%
23.98
+183.14%
8.47
+159.82%
3.26
Salaries And Wages
17.21
+43.08%
12.03
+151.69%
4.78
+132.60%
2.06
Other Gand A
11.47
-4.02%
11.95
+223.88%
3.69
+206.22%
1.21
Other Operating Expenses
—
1.88
+65.99%
1.13
+61.71%
0.70
Total Expenses
123.17
+97.71%
62.30
+139.05%
26.06
+34.14%
19.43
Operating Income
-123.17
-97.71%
-62.30
-139.05%
-26.06
-34.14%
-19.43
Total Operating Income As Reported
-123.17
-97.71%
-62.30
-139.05%
-26.06
-34.14%
-19.43
EBITDA
-113.80
-118.68%
-52.04
+45.09%
-94.77
-316.05%
-22.78
Normalized EBITDA
-113.80
-120.22%
-51.67
+36.29%
-81.11
-311.26%
-19.72
Reconciled Depreciation
0.51
+57.59%
0.32
+84.57%
0.17
-26.47%
0.24
EBIT
-114.31
-118.30%
-52.36
+44.85%
-94.95
-312.51%
-23.02
Total Unusual Items
0.00
+100.00%
-0.37
+97.32%
-13.66
-346.94%
-3.06
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-0.37
+97.32%
-13.66
-346.94%
-3.06
Special Income Charges
0.00
+100.00%
-0.37
+88.16%
-3.09
0.00
Other Special Charges
—
0.37
-88.16%
3.09
—
Net Income
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Pretax Income
-117.30
-112.65%
-55.16
+44.78%
-99.90
-308.76%
-24.44
Net Non Operating Interest Income Expense
6.43
-15.54%
7.62
+298.51%
-3.84
-196.45%
-1.29
Interest Expense Non Operating
2.99
+7.01%
2.80
-43.51%
4.95
+248.07%
1.42
Net Interest Income
6.43
-15.54%
7.62
+298.51%
-3.84
-196.45%
-1.29
Interest Expense
2.99
+7.01%
2.80
-43.51%
4.95
+248.07%
1.42
Interest Income Non Operating
9.43
-9.48%
10.41
+832.23%
1.12
+765.89%
0.13
Interest Income
9.43
-9.48%
10.41
+832.23%
1.12
+765.89%
0.13
Other Income Expense
-0.57
-18.79%
-0.48
+99.32%
-70.00
-1782.33%
-3.72
Other Non Operating Income Expenses
-0.57
-403.54%
-0.11
+99.80%
-56.34
-8410.73%
-0.66
Gain On Sale Of Security
—
—
-10.57
-245.83%
-3.06
Tax Provision
0.00
+100.00%
-0.02
-211.76%
0.02
-22.73%
0.02
Tax Rate For Calcs
0.00
-100.00%
0.00
-99.93%
0.00
+52.61%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.00
+100.00%
-5.47
-582.09%
-0.80
Net Income Including Noncontrolling Interests
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Net Income From Continuing Operation Net Minority Interest
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Net Income From Continuing And Discontinued Operation
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Net Income Continuous Operations
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Normalized Income
-117.30
-114.15%
-54.78
+40.28%
-91.72
-313.03%
-22.21
Net Income Common Stockholders
-117.30
-112.73%
-55.14
+47.35%
-104.74
-260.87%
-29.02
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-2.29
-56.85%
-1.46
+67.66%
-4.52
-260.87%
-1.25
Basic EPS
-2.29
-56.85%
-1.46
+67.66%
-4.52
-260.87%
-1.25
Basic Average Shares
51.12
+35.30%
37.78
+62.87%
23.20
+0.00%
23.20
Diluted Average Shares
51.12
+35.30%
37.78
+62.87%
23.20
+0.00%
23.20
Diluted NI Availto Com Stockholders
-117.30
-112.73%
-55.14
+47.35%
-104.74
-260.87%
-29.02
Preferred Stock Dividends
—
—
4.82
+5.70%
4.56
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Assets
221.47
-28.83%
311.17
+257.84%
86.96
+263.71%
23.91
Current Assets
201.39
-18.58%
247.36
+189.52%
85.44
+278.34%
22.58
Cash Cash Equivalents And Short Term Investments
193.74
-18.71%
238.33
+192.36%
81.52
+298.95%
20.43
Cash And Cash Equivalents
50.15
-71.01%
173.00
+112.22%
81.52
+298.95%
20.43
Other Short Term Investments
143.58
+119.79%
65.33
0.00
—
Receivables
0.93
+179.22%
0.33
-85.83%
2.34
+75.37%
1.34
Taxes Receivable
0.93
+179.22%
0.33
-85.83%
2.34
+75.37%
1.34
Restricted Cash
0.08
+9.72%
0.07
-5.26%
0.08
+2.70%
0.07
Other Current Assets
6.65
-22.92%
8.63
+475.07%
1.50
+102.98%
0.74
Total Non Current Assets
20.08
-68.54%
63.81
+4100.86%
1.52
+14.56%
1.33
Net PPE
10.19
+250.27%
2.91
+394.06%
0.59
+52.20%
0.39
Gross PPE
12.30
+172.04%
4.52
+95.16%
2.32
+19.38%
1.94
Accumulated Depreciation
-2.10
-30.62%
-1.61
+6.77%
-1.73
-11.20%
-1.55
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
7.72
+343.19%
1.74
0.00
0.00
Machinery Furniture Equipment
1.18
+239.26%
0.35
-14.46%
0.41
+17.92%
0.35
Other Properties
3.13
+43.04%
2.19
+23.16%
1.78
+20.86%
1.47
Leases
0.26
+9.62%
0.24
+85.27%
0.13
+5.74%
0.12
Investments And Advances
8.52
-85.68%
59.53
0.00
—
Other Non Current Assets
1.36
-0.87%
1.37
+47.74%
0.93
-0.96%
0.94
Total Liabilities Net Minority Interest
53.76
+39.41%
38.56
+166.43%
14.47
-69.47%
47.41
Current Liabilities
31.98
+118.12%
14.66
+178.89%
5.26
+3.00%
5.10
Payables And Accrued Expenses
17.33
+76.17%
9.84
+161.12%
3.77
+19.13%
3.16
Payables
6.71
+375.34%
1.41
+18.08%
1.20
+60.40%
0.74
Accounts Payable
6.69
+373.99%
1.41
+22.06%
1.16
+59.89%
0.72
Current Accrued Expenses
10.63
+26.08%
8.43
+227.56%
2.57
+6.41%
2.42
Pensionand Other Post Retirement Benefit Plans Current
4.05
+16.63%
3.48
+326.90%
0.81
+20.41%
0.68
Total Tax Payable
0.02
0.00
-100.00%
0.04
+77.27%
0.02
Income Tax Payable
0.02
0.00
-100.00%
0.04
+77.27%
0.02
Current Debt And Capital Lease Obligation
10.02
+792.69%
1.12
+99.64%
0.56
-55.57%
1.26
Current Debt
8.00
+1044.78%
0.70
+24.38%
0.56
-55.57%
1.26
Other Current Borrowings
8.00
+1044.78%
0.70
+24.38%
0.56
-55.57%
1.26
Current Capital Lease Obligation
2.01
+376.12%
0.42
0.00
0.00
Other Current Liabilities
0.58
+156.44%
0.23
+99.12%
0.11
—
Total Non Current Liabilities Net Minority Interest
21.78
-8.87%
23.90
+159.33%
9.22
-78.21%
42.30
Long Term Debt And Capital Lease Obligation
21.78
-8.87%
23.90
+159.33%
9.22
-70.12%
30.84
Long Term Debt
15.32
-31.81%
22.47
+143.85%
9.22
-70.12%
30.84
Long Term Capital Lease Obligation
6.46
+352.35%
1.43
0.00
—
Preferred Securities Outside Stock Equity
—
—
0.00
-100.00%
53.12
Stockholders Equity
167.71
-38.48%
272.61
+276.09%
72.49
+408.50%
-23.50
Common Stock Equity
167.71
-38.48%
272.61
+276.09%
72.49
+194.61%
-76.61
Capital Stock
513.28
+0.68%
509.81
+96.56%
259.37
+273.16%
69.51
Common Stock
513.28
+0.68%
509.81
+96.56%
259.37
+1482.51%
16.39
Preferred Stock
—
—
0.00
-100.00%
53.12
Share Issued
52.02
+2.04%
50.98
+119.75%
23.20
+0.00%
23.20
Ordinary Shares Number
52.02
+2.04%
50.98
+119.75%
23.20
+0.00%
23.20
Additional Paid In Capital
27.35
+44.32%
18.95
+38.15%
13.72
+78.54%
7.68
Retained Earnings
-372.03
-46.05%
-254.73
-27.63%
-199.59
-100.25%
-99.67
Gains Losses Not Affecting Retained Earnings
-0.89
+37.42%
-1.42
-39.67%
-1.02
+0.00%
-1.02
Other Equity Adjustments
-0.89
+37.42%
-1.42
-39.67%
-1.02
+0.00%
-1.02
Total Equity Gross Minority Interest
167.71
-38.48%
272.61
+276.09%
72.49
+408.50%
-23.50
Total Capitalization
183.03
-37.97%
295.08
+261.17%
81.70
+1011.74%
7.35
Working Capital
169.41
-27.20%
232.70
+190.21%
80.18
+358.74%
17.48
Invested Capital
191.04
-35.41%
295.78
+259.55%
82.26
+284.85%
-44.50
Total Debt
31.80
+27.07%
25.02
+155.90%
9.78
-69.55%
32.11
Net Debt
—
—
—
11.68
Capital Lease Obligations
8.47
+357.78%
1.85
0.00
0.00
Net Tangible Assets
167.71
-38.48%
272.61
+276.09%
72.49
+408.50%
-23.50
Tangible Book Value
167.71
-38.48%
272.61
+276.09%
72.49
+194.61%
-76.61
Available For Sale Securities
8.52
-85.68%
59.53
—
—
Derivative Product Liabilities
—
—
0.00
-100.00%
11.46
Investmentin Financial Assets
8.52
-85.68%
59.53
0.00
—
Preferred Stock Equity
—
—
—
53.12
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Operating Cash Flow
-99.24
-105.54%
-48.28
-95.13%
-24.74
-40.65%
-17.59
Cash Flow From Continuing Operating Activities
-99.24
-105.54%
-48.28
-95.13%
-24.74
-40.65%
-17.59
Net Income From Continuing Operations
-117.30
-112.73%
-55.14
+44.81%
-99.92
-308.46%
-24.46
Depreciation Amortization Depletion
0.51
+57.59%
0.32
+84.57%
0.17
-26.47%
0.24
Depreciation
0.51
+57.59%
0.32
+84.57%
0.17
-26.47%
0.24
Depreciation And Amortization
0.51
+57.59%
0.32
+84.57%
0.17
-26.47%
0.24
Other Non Cash Items
1.23
+27.14%
0.97
-43.07%
1.70
+166.35%
0.64
Stock Based Compensation
9.65
+81.18%
5.32
+54.32%
3.45
+2874.14%
0.12
Operating Gains Losses
0.00
-99.21%
0.38
-97.30%
14.15
+282.18%
3.70
Gain Loss On Investment Securities
—
—
10.57
+245.83%
3.06
Unrealized Gain Loss On Investment Securities
—
0.00
-100.00%
56.21
0.00
Net Foreign Currency Exchange Gain Loss
0.00
+150.00%
-0.01
-101.23%
0.49
-24.30%
0.65
Gain Loss On Sale Of PPE
0.00
-100.00%
0.02
0.00
—
Change In Working Capital
9.74
+10152.63%
0.10
+118.38%
-0.52
-123.78%
2.17
Change In Receivables
-0.59
-129.59%
2.01
+299.70%
-1.01
-804.20%
0.14
Change In Prepaid Assets
1.99
+126.29%
-7.57
-907.46%
-0.75
-564.60%
-0.11
Change In Payables And Accrued Expense
8.07
+41.64%
5.70
+359.23%
1.24
-42.12%
2.14
Change In Accrued Expense
3.13
-40.10%
5.22
+501.96%
0.87
-62.92%
2.34
Change In Payable
4.94
+942.62%
0.47
+27.08%
0.37
+289.34%
-0.20
Change In Account Payable
4.94
+942.62%
0.47
+27.08%
0.37
+289.34%
-0.20
Change In Other Current Liabilities
0.27
+659.18%
-0.05
0.00
—
Investing Cash Flow
-25.14
+80.04%
-125.95
-39507.86%
-0.32
-107.84%
-0.15
Cash Flow From Continuing Investing Activities
-25.14
+80.04%
-125.95
-39507.86%
-0.32
-107.84%
-0.15
Net PPE Purchase And Sale
-1.49
-60.54%
-0.93
-190.88%
-0.32
-107.84%
-0.15
Purchase Of PPE
-1.49
-60.54%
-0.93
-190.88%
-0.32
-107.84%
-0.15
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-1.49
-60.54%
-0.93
-190.88%
-0.32
-107.84%
-0.15
Net Investment Purchase And Sale
-23.65
+81.08%
-125.03
0.00
—
Purchase Of Investment
-160.84
-28.65%
-125.03
0.00
—
Sale Of Investment
137.19
0.00
—
—
Financing Cash Flow
1.52
-99.43%
265.72
+208.44%
86.15
+208.03%
27.97
Cash Flow From Continuing Financing Activities
1.52
-99.43%
265.72
+208.44%
86.15
+208.03%
27.97
Net Issuance Payments Of Debt
-0.70
-105.35%
13.05
-60.76%
33.27
+17.19%
28.39
Issuance Of Debt
0.00
-100.00%
22.50
-40.79%
38.00
+29.25%
29.40
Repayment Of Debt
-0.70
+92.60%
-9.45
-99.64%
-4.73
-368.42%
-1.01
Long Term Debt Issuance
0.00
-100.00%
22.50
-40.79%
38.00
+29.25%
29.40
Long Term Debt Payments
-0.70
+92.60%
-9.45
-99.64%
-4.73
-368.42%
-1.01
Net Long Term Debt Issuance
-0.70
-105.35%
13.05
-60.76%
33.27
+17.19%
28.39
Net Common Stock Issuance
0.00
-100.00%
260.15
+357.27%
56.89
0.00
Proceeds From Stock Option Exercised
2.22
-63.53%
6.10
+13754.55%
0.04
+266.67%
0.01
Net Other Financing Charges
—
-13.58
-234.75%
-4.06
-832.87%
-0.43
Changes In Cash
-122.85
-234.29%
91.48
+49.76%
61.09
+497.59%
10.22
Effect Of Exchange Rate Changes
0.00
+0.00%
0.00
+0.00%
0.00
+100.12%
-0.81
Beginning Cash Position
173.00
+112.22%
81.52
+298.95%
20.43
+85.48%
11.02
End Cash Position
50.15
-71.01%
173.00
+112.22%
81.52
+298.95%
20.43
Free Cash Flow
-100.72
-104.70%
-49.21
-96.34%
-25.06
-41.23%
-17.75
Interest Paid Supplemental Data
2.29
+18.91%
1.93
+37.70%
1.40
+127.32%
0.61
Amortization Of Securities
-3.07
-1221.98%
-0.23
0.00
—
Common Stock Issuance
0.00
-100.00%
260.15
+357.27%
56.89
0.00
Issuance Of Capital Stock
0.00
-100.00%
260.15
+357.27%
56.89
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category